A new medical review has found that some rare uterine cancers, which mimic certain features of pregnancy, are often aggressive and linked to worse survival rates.
The study, published in Oncoscience on September 4, 2025, analyzed cases of uterine tumors that either produce the hormone beta-human chorionic gonadotropin (β-hCG) or develop “trophoblastic differentiation,” a process in which cancer cells begin to resemble the placental cells normally formed during pregnancy.
Researchers from the All India Institute of Medical Sciences, Bibinagar, reviewed 40 published cases and concluded that these tumors behave more aggressively than typical uterine cancers, often spreading early and showing resistance to standard treatments.
Key Findings
Aggressive behavior: These cancers tend to spread quickly, especially to the lungs.
Treatment challenges: They often do not respond well to chemotherapy or radiation.
Patient profile: Most affected patients were postmenopausal women, many with risk factors such as obesity, diabetes, or hypertension.
Symptoms: Abnormal or postmenopausal bleeding was the most common sign.
Survival rates: Nearly half of patients died within 10 months of diagnosis; only about 30% were disease-free after treatment.
Treatment Insights
Currently, there is no standardized treatment for this rare cancer subtype. However, some patients in the review responded better to EMACO chemotherapy—a regimen typically used for gestational trophoblastic disease. In the few cases where EMACO was used, patients survived longer compared to other treatment approaches.
This suggests EMACO could be a potential option, but more research is needed before it can be widely recommended.
Why It Matters
Because these cancers are rare and often overlooked, recognizing pregnancy-like features such as β-hCG production may help doctors identify patients at higher risk and adjust treatment strategies sooner.
The study highlights the importance of early detection and thorough staging, but even early-stage cases were often advanced, underscoring the urgent need for better diagnostic tools.
Takeaway
While uterine cancers with pregnancy-like features are uncommon, they pose serious challenges. Doctors and patients may benefit from increased awareness, closer monitoring, and more personalized treatment approaches to improve survival outcomes.
YOU MAY ALSO LIKE
